Overall verdict
Neutral
6.2/10
1-year performance
-33.40%
Score breakdown
Down 33.4% over 1 year, 31% of the 52-week range.
Strongest: Valuation 9.3/10. Weakest: Growth 3.4/10.
12 analysts, target +0.3% vs the price.
3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America.
It makes private equity investments in business and technology services, financial services, consumer and private label, software and service, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification ; intelligent outsourcing, BPO and consultancy ;
human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses ; facilities management ; support services to industrial sectors such as oil and gas and utilities ; human resources outsourcing and advising ; recruitment ; logistics and infrastructure support services including distribution, waste, and rental.
In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; private label CMO and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, personalized medicine, pharmaceuticals and biotechnology including specialty pharma, generics or OTC, drug delivery, and animal health ;
healthcare services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, clinical services and B2B contract services ; medical devices and technology including devices, medical equipment and consumables, diagnostics, and healthcare IT. In services and software, it focuses on IT services including cloud and IT infrastructure managed services providers, software vendor integration and support services or application, and software development or DevOps ;
tech-enabled outsourcing services including testing, inspection and certification, human capital management or business information, and data & analytics ; mature software including horizontal software, vertical software, office of the CFO, supply chain, ERP, human capital and life sciences. In the industrial sector, it focuses on automotive, chemicals, safety and security, construction, building products and materials, energy, electronics and electrical components, flow control and filtration, mobility, packaging, industrial CMO, B2B distribution, safety & security, industrial services including industrial software, oil, gas, and power.
Through 3i BIFM Limited and 3i Infrastructure plc the firm makes infrastructure investments where it focuses principally on the utilities including energy transmission and storage, electricity and gas distribution, water, power generation, and communication network ; transportation including airports, ports, ferries, toll roads, and rail ; and social infrastructure sector including primary and secondary PFI, public private partnerships, healthcare, education, and government accommodation.
In infrastructure it invests primarily in utilities, transportation and social infrastructure in the United Kingdom, France, Italy, Germany, Europe, and Ireland. The firm prefers to invest in companies across Europe, France, United States, South America, and Asia. It seeks to make new investments in Northern Europe and North America.
The firm typically invests in companies with enterprise value between 100 million ($115.58 million) and 500 million ($577.90 million). It seeks to make investments of £150 million ($200.80 million) and £300million ($401.59 million) in companies, taking control positions, and target mid-teen investment returns in infrastructure sector. It seeks to take either majority or minority stakes.
It seeks to take a board seat in its portfolio companies with regards to infrastructure investments. The firm invests through a combination of third-party and proprietary capital. It invests through its personal capital. 3i Group plc was founded in 1945 and is based in London, United Kingdom with additional offices across North America, Asia and Europe.
Sector
Financials
Industry
Capital Markets
Primary listing
Lse
United Kingdom
CEO
Mr. Simon Alexander Borrows
Founded
1945
Employees
248
Revenue / employee
5.1M GBP
Next earnings
November 12, 2026
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
44.97 GBP
52-week low
18.25 GBP
1-year performance
-33.40%
Declining
Year-to-date performance
-19.50%
Declining
Drawdown
-40.78%
Major drawdown
Position in the 52-week range
31% of range
Range: 70.43 GBP - 74.81 GBP (comparables only)
The price implies growth of 27.70% per year; the company grows at 22.92%.
Gross margin 99.6%, net margin 420.2%, ROIC 18.3%, ROE 19.1%.
Net margin
420.16%
Exceptional
Sector 24.49%|S&P 12.97%
Gross margin
99.60%
High
Return on equity (ROE)
19.08%
Exceptional
Sector 12.29%|S&P 16.52%
Return on invested capital (ROIC)
18.26%
Exceptional
Free cash flow margin (FCF)
19.52%
Low
Profit-to-cash conversion (FCF conversion)
0.05x
Low
Margin stability
1.0 pts
Very steady
Growth
3.4/10Revenue down 33.4% over 1 year, 39.6% a year over 5, EPS 22.9% a year over 5.
Revenue (trailing 12 months)
1.3Md GBP
Revenue growth (1y)
-33.40%
Declining
Revenue growth (3y)
108.09%
Strong
EPS growth (1y)
-35.00%
Declining
EPS CAGR (5y)
22.92%
Exceptional
EPS revisions (3 months)
-3.13%
Revised down
Valuation
9.3/10P/E 4.9x, forward P/E 5.1x, EV/EBITDA 5.2x, PEG 0.22.
P/E (TTM)
4.9x
Cheap
Sector 15.9x|S&P 23.0x
Forward P/E
5.1x
Cheap
EV / EBITDA
5.2x
Cheap
Sector 13.7x|S&P 14.5x
PEG
0.22
Growth unpriced
Sector 0.03|S&P 0.86
Fair value (reverse DCF)
72.62 GBP
Deeply undervalued
Market cap
27.1Md GBP
Financial strength
6.8/10Cash covers 50.4% of the debt, net debt/EBITDA 0.1x.
Net debt / EBITDA
0.1x
Very solid
Gearing (net debt / equity)
2.03%
Stretched
Cash
635M GBP
Cash / market cap
2.35%
Stretched
Cash / total debt
50.36%
Solid
Net debt
626M GBP
Equity
30.9Md GBP
Closed daily candles, 2 years
Last close on September 24, 2026: 26.17 GBP
- MM2027.16
- MM5027.59
- MM20028.03
- RSI 1440.5
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-2.33%
200-day average slope, 3 months
-11.82%
50-day average slope, 1 month
+3.48%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
1.60 % per day
Volatility change
-43.40%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2027 | 5.19 (7) | 5.15 (10) | 5 290 (7) | 7 355 (1) | 5 144 (5) |
Amounts in millions of GBP, EPS in GBP per share. In brackets, the number of analysts. Consensus as of September 10, 2026.
Same sub-industry: 205 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AMP | 7.2 | 8.1 | 44.4Md USD | 12.1x | 19.9 % | 11.7 % | 32.1 % | -0.8x | 18.5 % | -1.9 % | ||
| 2 | III | 6.2 | 6.9 | 35.8Md USD | 4.9x | 420.2 % | -33.4 % | 18.3 % | 0.1x | 0.9 % | -33.4 % | ||
| 3 | BNY | 6.1 | 5.6 | 101Md USD | 17.4x | 29.6 % | -1.6 % | 8.3 % | — | 1.6 % | 37.6 % | ||
| 4 | BX | 6.0 | 5.7 | 148Md USD | 26.8x | 22.1 % | 33.2 % | 16.2 % | 1.4x | 1.3 % | -36.6 % | ||
| 5 | STT | 5.9 | 4.7 | 49.4Md USD | 15.9x | 24.9 % | 3.2 % | 6.4 % | — | -8.3 % | 60.0 % | ||
| 6 | BLK | 5.7 | 4.4 | 172Md USD | 26.4x | 23.8 % | 22.4 % | 9.6 % | 0.4x | 2.0 % | -5.3 % | ||
| 7 | BAM | 5.6 | 5.0 | 74.1Md USD | 26.7x | 48.9 % | 60.8 % | 27.5 % | 0.7x | 3.2 % | -27.1 % | ||
| 8 | KKR | 5.2 | 4.1 | 87.3Md USD | 31.0x | 13.4 % | 20.4 % | 3.8 % | 6.4x | 10.4 % | -34.6 % | ||
| 9 | BN | 4.0 | 3.2 | 82.7Md USD | 70.1x | 1.8 % | 9.2 % | 0.5 % | 8.1x | -11.1 % | -21.4 % |
